arthyperАртериальная гипертензия"Arterial’naya Gipertenziya" ("Arterial Hypertension")1607-419X2411-8524Antihypertensive League10.18705/1607-419X-2010--2-arthyper-1540Research ArticleКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯCLINICAL TRIALSВлияние терапии блокаторами рецепторов к ангиотензину II на развитие когнитивных расстройств у больных артериальной гипертензией: результаты исследования OSCAREffects of angiotensin II receptor antagonist treatment on the risk of cognitive impairment in patients with hypertension: OSCAR resultsШляхтоЕ. В.ShlyakhtoE. V.noemail@neicon.ruЗуеваИ. Б.ZuevaI. B.noemail@neicon.ruФГУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»РоссияAlmazov Federal Heart, Blood and Endocrinology Centre, St PetersburgRussian Federation201028042010162219222Copyright © Шляхто Е.В., Зуева И.Б., 20102010Шляхто Е.В., Зуева И.Б.Shlyakhto E.V., Zueva I.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://htn.almazovcentre.ru/jour/article/view/1540
.
.
ОСКАРартериальная гипертензиякогнитивные функцииблокаторы рецепторов к ангиотензину IIOSCARhypertensioncognitive functionsangiotensin II receptor antagonistReferencesLezak M.D. Neuropsychology assessment. - N.Y.: University Press, 1983. - 768 p.Lezak M.D. Neuropsychology assessment. - N.Y.: University Press, 1983. - 768 p.Захаров В.В., Яхно Н.Н. Когнитивные расстройства в пожилом и старческом возрасте: Метод. пособие для врачей. - М., 2005.Захаров В.В., Яхно Н.Н. Когнитивные расстройства в пожилом и старческом возрасте: Метод. пособие для врачей. - М., 2005.Guo Z., Fratiglioni L., Zhu L., Fastbom J., Winblad B., Viitanen M. Occurrence and progression of dementia in community population aged 75 years and older // Arch. Neurol. - 1999. - Vol. 56, № 8. - P. 991-996.Guo Z., Fratiglioni L., Zhu L., Fastbom J., Winblad B., Viitanen M. Occurrence and progression of dementia in community population aged 75 years and older // Arch. Neurol. - 1999. - Vol. 56, № 8. - P. 991-996.Amery A., Birkenhager W., Brixko P. et al. Mortality and morbidity results from the European Working Party on high blood pressure in the elderly trial // Lancet. - 1985. - Vol. 1, № 8442. - P. 1349-1354.Amery A., Birkenhager W., Brixko P. et al. Mortality and morbidity results from the European Working Party on high blood pressure in the elderly trial // Lancet. - 1985. - Vol. 1, № 8442. - P. 1349-1354.Whitmer R.A., Sidney S., Selby J. et al. Midlife cardiovascular risk factors and risk of dementia in late life // Neurology. - 2005. - Vol. 64, № 2. - P. 277-281.Whitmer R.A., Sidney S., Selby J. et al. Midlife cardiovascular risk factors and risk of dementia in late life // Neurology. - 2005. - Vol. 64, № 2. - P. 277-281.Forette F., Seux M.L., Staessen J.A. et al. Systolic hypertension in Europe investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study // Arch. Intern. Med. - 2002. - Vol. 162, № 18. - P. 2046-2052.Forette F., Seux M.L., Staessen J.A. et al. Systolic hypertension in Europe investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study // Arch. Intern. Med. - 2002. - Vol. 162, № 18. - P. 2046-2052.Tzourio C., Anderson C., Chapman N. et al. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease // Arch. Intern. Med. - 2003. - Vol. 163, № 9. - P. 1069-1075.Tzourio C., Anderson C., Chapman N. et al. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease // Arch. Intern. Med. - 2003. - Vol. 163, № 9. - P. 1069-1075.Lithell H., Hansson L., Skoog I. et al. SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial // J. Hypertens. - 2003. - Vol. 21, № 5. - P. 875-886.Lithell H., Hansson L., Skoog I. et al. SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial // J. Hypertens. - 2003. - Vol. 21, № 5. - P. 875-886.SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP) // J. Am. Med. Assoc. - 1991. - Vol. 265, № 24. - P. 3255-3264.SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP) // J. Am. Med. Assoc. - 1991. - Vol. 265, № 24. - P. 3255-3264.Ellul J., Archer N., Foy C.M. et al. The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration // J. Neurol. Neurosurg. Psychiatry. - 2007. - Vol. 78, № 3. - P. 233-239.Ellul J., Archer N., Foy C.M. et al. The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration // J. Neurol. Neurosurg. Psychiatry. - 2007. - Vol. 78, № 3. - P. 233-239.Hoogwerf B.J., Young J.B. The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not // Cleve Clin. J. Med. - 2002. - Vol. 67, № 4. - P. 287-293.Hoogwerf B.J., Young J.B. The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not // Cleve Clin. J. Med. - 2002. - Vol. 67, № 4. - P. 287-293.Tedesco M.A., Ratti G., Mennella S. et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients // Am. J. Hypertens. - 1999. - Vol. 12, № 11 (Pt. 1). - P. 1130-1134.Tedesco M.A., Ratti G., Mennella S. et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients // Am. J. Hypertens. - 1999. - Vol. 12, № 11 (Pt. 1). - P. 1130-1134.Schrander J., Luders S., Kulschewski A. et al. Morbidity and mortality after stroke, eprosartran compared with netrendipine for secondary prevention (MOSES study) // Stroke. - 2005. - Vol. 36, № 6. - P. 1218-1226.Schrander J., Luders S., Kulschewski A. et al. Morbidity and mortality after stroke, eprosartran compared with netrendipine for secondary prevention (MOSES study) // Stroke. - 2005. - Vol. 36, № 6. - P. 1218-1226.Elias M.F </pubmed?term=%22Elias%20MF%22%5BAuthor%5D>., Robbins M.A </pubmed?term=%22Robbins%20MA%22%5BAuthor%5D>., Budge M.M </pubmed?term=%22Budge%20MM%22%5BAuthor%5D>., Abhayaratna W.P </pubmed?term=%22Abhayaratna%20WP%22%5BAuthor%5D>., Dore G.A </pubmed?term=%22Dore%20GA%22%5BAuthor%5D>., Elias P.K </pubmed?term=%22Elias%20PK%22%5BAuthor%5D>. Arterial pulse wave velocity and cognition with advancing age // J. Hypertension. - 2009. - Vol. 53, № 4. - P. 668-673.Elias M.F </pubmed?term=%22Elias%20MF%22%5BAuthor%5D>., Robbins M.A </pubmed?term=%22Robbins%20MA%22%5BAuthor%5D>., Budge M.M </pubmed?term=%22Budge%20MM%22%5BAuthor%5D>., Abhayaratna W.P </pubmed?term=%22Abhayaratna%20WP%22%5BAuthor%5D>., Dore G.A </pubmed?term=%22Dore%20GA%22%5BAuthor%5D>., Elias P.K </pubmed?term=%22Elias%20PK%22%5BAuthor%5D>. Arterial pulse wave velocity and cognition with advancing age // J. Hypertension. - 2009. - Vol. 53, № 4. - P. 668-673.Pathak A., Hanon O., Negre-Pages L., Sevenier F. Rationale, design and methods of the OSCAR study:observational study on cognitive function and systolic blood pressure reduction in hypertensive patients // Fundam. Clin. Pharmacol. - 2007. - Vol. 21, № 2. - P. 199-205.Pathak A., Hanon O., Negre-Pages L., Sevenier F. Rationale, design and methods of the OSCAR study:observational study on cognitive function and systolic blood pressure reduction in hypertensive patients // Fundam. Clin. Pharmacol. - 2007. - Vol. 21, № 2. - P. 199-205.Plosker G.L. Eprosartan: a review of its use in hypertension // Drugs. - 2009. - Vol. 69, № 17. - P. 2477-2499.Plosker G.L. Eprosartan: a review of its use in hypertension // Drugs. - 2009. - Vol. 69, № 17. - P. 2477-2499.Scuteri A., Tesauro M., Appolloni S., Preziosi F., Brancati A.M., Volpe M. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual // J. Hypertens. - 2007. - Vol. 25, № 5. - P. 1035-1040.Scuteri A., Tesauro M., Appolloni S., Preziosi F., Brancati A.M., Volpe M. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual // J. Hypertens. - 2007. - Vol. 25, № 5. - P. 1035-1040.Hanon O., Haulon S., Lenoir H. et al. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss // Stroke. - 2005. - Vol. 36, № 10. - P. 2193-2197.Hanon O., Haulon S., Lenoir H. et al. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss // Stroke. - 2005. - Vol. 36, № 10. - P. 2193-2197.Fournier A., Messerly F., Archad J. et al. Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent clinical trials // J. Am. Coll. Cardiol. - 2004. - Vol. 43, № 8. - P. 1343-1347.Fournier A., Messerly F., Archad J. et al. Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent clinical trials // J. Am. Coll. Cardiol. - 2004. - Vol. 43, № 8. - P. 1343-1347.Ohlstein E.H., Brooks D.P., Feuerstein G.Z., Ruffolo R.R. Jr. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade // Pharmacology. -1997. - Vol. 55, № 5. - P. 244-251.Ohlstein E.H., Brooks D.P., Feuerstein G.Z., Ruffolo R.R. Jr. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade // Pharmacology. -1997. - Vol. 55, № 5. - P. 244-251.Guimaraes S., Pinheiro H., Tavares P., Loio A., Moura D. Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors // Naunyn Schmiedebergs Arch. Pharmacol. - 2001. - Vol. 363, № 5. - P. 509-514.Guimaraes S., Pinheiro H., Tavares P., Loio A., Moura D. Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors // Naunyn Schmiedebergs Arch. Pharmacol. - 2001. - Vol. 363, № 5. - P. 509-514.
The authors declare that there are no conflicts of interest present.